The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Maximilian LennartzThorsten Schlomm

Abstract

Aberrant DNA content has been discussed as a potential prognostic feature in prostate cancer. We analyzed the clinical significance of DNA ploidy in combination with prognostic relevant deletions of PTEN and 6q15 in 3,845 prostate cancers. The DNA status was diploid in 67.8%, tetraploid in 25.6%, and aneuploid in 6.8% of tumors, and deletions of PTEN and 6q15 occurred in 17.8% and 20.3% of tumors. Abnormal DNA content and deletions were linked to high Gleason score, advanced tumor stage, and positive nodal stage (P < 0.0001 each). The risk of PSA recurrence increased from diploid to tetraploid and from tetraploid to aneuploid DNA status (P < 0.0001 each). However, 40% of patients with Gleason score ≥4+4 and 55% of patients with PSA recurrence had diploid cancers. This fraction decreased to 21% (Gleason ≥4+4) and 29% (PSA recurrence) if PTEN and/or 6q deletion data were added to ploidy data to identify cancers with an aberrant DNA status. The significance of combining both deletions and ploidy was further demonstrated in a combined recurrence analysis. Presence of deletions increased the risk of PSA recurrence in diploid (P < 0.0001), tetraploid (P < 0.0001), and aneuploid cancers (P = 0.0049), and the combination of ploidy data...Continue Reading

References

Jan 1, 1992·European Urology·F Di SilverioD Forte
Feb 15, 1990·International Journal of Cancer. Journal International Du Cancer·O A Haugen, O Mjølnerød
Jan 1, 1990·Journal of Cancer Research and Clinical Oncology·J HemmerS Haase
Nov 1, 1983·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·D W HedleyE A Musgrove
Jan 1, 1982·Scandinavian Journal of Urology and Nephrology·H GustafsonP L Esposti
Jan 1, 1994·Virchows Archiv : an International Journal of Pathology·J G MüllerH A Müller
Jul 5, 2003·World Journal of Urology·C DeliveliotisV Protogerou
May 27, 2004·Technology in Cancer Research & Treatment·Duke K BahnJohn C Rewcastle
Mar 16, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ahmedin JemalMichael J Thun
Jun 9, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mark A RubinJan-Erik Johansson
Sep 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wennuan LiuJianfeng Xu
Apr 9, 2008·Journal of Cancer Research and Clinical Oncology·M BurchardtM A Rubin
Jun 17, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Thorsten SchlommAndreas Erbersdobler
May 6, 2009·Annals of Internal Medicine·John ConcatoCarolyn K Wells
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Li-Yan KhorAlan Pollack
May 4, 2011·Virchows Archiv : an International Journal of Pathology·Achim FleischmannGeorge N Thalmann
Nov 21, 2012·Prostate Cancer and Prostatic Diseases·N VasiljevićA T Lorincz
Feb 2, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Martina KluthSarah Minner

❮ Previous
Next ❯

Citations

Feb 2, 2017·International Journal of Molecular Sciences·Nathaniel MellingWaldemar Wilczak
Jun 27, 2017·Current Opinion in Urology·James T Kearns, Daniel W Lin
Jan 4, 2018·Nature Reviews. Clinical Oncology·Laurent SansregretCharles Swanton
Sep 25, 2019·Nature Reviews. Genetics·Uri Ben-David, Angelika Amon
Jun 3, 2017·Der Urologe. Ausg. A·A KretschmerG Kristiansen
Aug 25, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Yogesh M BramhechaJacques Lapointe
Nov 22, 2017·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Klaske M Schukken, Floris Foijer
Jan 21, 2017·Oncology Letters·Nazanin SharifiAbbas Shakoori
Sep 21, 2017·The Prostate·Christoph BurdelskiFrank Jacobsen
Oct 11, 2017·Molecular Cancer Research : MCR·Yogesh M BramhechaJacques Lapointe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.